There were 4.0% of participants who died because of serious adverse reactions.
This was 2 out of 50 participants.
X There was 1 participant in Group 1 who died because of a serious adverse
reaction.
X There was 1 participant in Group 2 who died because of a serious adverse
reaction.
What adverse reactions happened during this study?
The most common adverse reaction was low red blood cell counts.
The table below shows the adverse reactions that happened in 4 or more
participants during the study. There were other adverse reactions, but these
happened in fewer participants.
Most common adverse reactions
Group 1 Group 2
Adverse reaction (out of 27 participants) (out of 23 participants)
Low red blood cell counts 33.3% (9) 30.4% (7)
Low levels of neutrophils, a type of white blood 11.1% (3) 34.8% (8)
cell that fights infection
Diarrhea 14.8% (4) 21.7% (5)
Low white blood cell counts with fever 22.2% (6) 8.7% (2)
Low blood platelet counts, which can lead to 11.1% (3) 17.4% (4)
bleeding and bruising
Decreased blood platelet counts 18.5% (5) 8.7% (2)
Fatigue 14.8% (4) 8.7% (2)
Dizziness 7.4% (2) 8.7% (2)
Nausea 0.0% (0) 17.4% (4)
Vomiting 0.0% (0) 17.4% (4)
10 | Clinical Study Results